Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502239989

Apexbio Technology LLC Amyloid β-Peptide (1-42) (human),1mg CAS# 107761-42-2
SDP

Catalog No. 502239989
Encompass_Preferred

Amyloid β-Peptide (1-42) (Aβ42) human is a 42-amino acid peptide that plays a key role in the pathogenesis of Alzheimer disease (AD) [1].The main deleterious effects in the pathogenesis are probably regulated by Aβ42, which acts as a repressor or activator of gene transcription causing further synaptic function damage and neuronal degeneration [2].Aβ42 reduced the viability of SH-SY5Y cells to 65% when it rose to 2.5 μM. Using the chromatin immunoprecipitation (ChIP) and qRT-PCR assays, treatment of SH-SY5Y cells with Aβ42 associated peptide with both LRP1 and KAI1 promoters and increased APP mRNA levels, while the nontoxic Aβ42 G33A peptide, as a control group which presents in the nucleus abundantly, did not have any influence on mRNA expression. The exclusive increase of transcription and expression of its precursor gene APP was found with the treatment of Aβ42, compared with several different lengths of peptides [1]. Other sizes are also available. Please inqury us for quote.

This item is not returnable. View return policy
Catalog No. 50-223-9989 Supplier Apexbio Technology LLC Supplier No. B60571
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Amyloid β-Peptide (1-42) (Aβ42) human is a 42-amino acid peptide that plays a key role in the pathogenesis of Alzheimer disease (AD) [1].The main deleterious effects in the pathogenesis are probably regulated by Aβ42, which acts as a repressor or activator of gene transcription causing further synaptic function damage and neuronal degeneration [2].Aβ42 reduced the viability of SH-SY5Y cells to 65% when it rose to 2.5 μM. Using the chromatin immunoprecipitation (ChIP) and qRT-PCR assays, treatment of SH-SY5Y cells with Aβ42 associated peptide with both LRP1 and KAI1 promoters and increased APP mRNA levels, while the nontoxic Aβ42 G33A peptide, as a control group which presents in the nucleus abundantly, did not have any influence on mRNA expression. The exclusive increase of transcription and expression of its precursor gene APP was found with the treatment of Aβ42, compared with several different lengths of peptides [1]. Other sizes are also available. Please inqury us for quote.

This item is not returnable. View return policy
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.